AnGes, Inc.
Biopharmaceutical firm developing gene-based and nucleotide-based medicines.
4563 | T
Overview
Corporate Details
- ISIN(s):
- JP3127700007
- LEI:
- Country:
- Japan
- Address:
- 茨木市彩都あさぎ七丁目７番１５号
- Website:
- https://www.anges.co.jp/en/
- Sector:
- Manufacturing
Description
AnGes, Inc. is a biopharmaceutical company specializing in the research and development of gene-based and nucleotide-based medicines. The company's core focus is its Hepatocyte Growth Factor (HGF) gene therapy product, designed to treat ischemic diseases by regenerating blood vessels. This product was the first gene therapy medicine to receive marketing approval in Japan. AnGes leverages its expertise in plasmid DNA technology across its development pipeline, which also includes an NFkB decoy oligonucleotide and DNA vaccines. The company is dedicated to developing novel treatments for various conditions, including rare diseases.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2016-11-11 01:17 |
四半期報告書－第18期第3四半期(2016/07/01－2016/09/30)
|
Japanese | 271.8 KB | ||
| 2016-08-12 02:28 |
四半期報告書－第18期第2四半期(2016/04/01－2016/06/30)
|
Japanese | 323.1 KB | ||
| 2016-05-12 02:20 |
四半期報告書－第18期第1四半期(2016/01/01－2016/03/31)
|
Japanese | 196.2 KB | ||
| 2016-03-31 07:15 |
有価証券報告書－第17期(2015/01/01－2015/12/31)
|
Japanese | 1.0 MB | ||
| 2015-11-11 01:14 |
四半期報告書－第17期第3四半期(2015/07/01－2015/09/30)
|
Japanese | 194.2 KB |
Automate Your Workflow. Get a real-time feed of all AnGes, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AnGes, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AnGes, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
